医薬品市場の概要、競合分析と予測、2018-2027年Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 医薬品市場の概要、競合分析と予測、2018-2027年 概要 世界の医薬品産業プロファイルは、市場シェア、市場規模(2017-22年値、2027年予測)など、トップラインの定性的および定量的サマリー情報を提供しま... もっと見る
サマリー医薬品市場の概要、競合分析と予測、2018-2027年概要 世界の医薬品産業プロファイルは、市場シェア、市場規模(2017-22年値、2027年予測)など、トップラインの定性的および定量的サマリー情報を提供します。このプロファイルには、主要な財務指標や市場内の競争圧力の分析を含む主要企業の説明も含まれています。 主要ハイライト - 医薬品市場は医療用医薬品のみで構成され、コンシューマーヘルスケアやアニマルヘルスケアは含まれない。 - 市場価値は工場出荷価格(メーカーが流通業者に医薬品を販売する際の価格)で算出されている。 - - すべての市場データおよび予測は名目ベース(すなわち、インフレ調整なし)で表され、本レポートの作成に使用したすべての通貨換算は、恒常為替レート(2022年の年間平均為替レート)を用いて計算されている。 - 世界の医薬品市場の2022年の総売上高は1兆2,993億ドルで、2017年から2022年までの年平均成長率(CAGR)は5.5%であった。 - 2022年の世界医薬品市場におけるアジア太平洋地域のシェアは32.7%であった。世界の医薬品市場の成長は、主に中国やインドなどの新興市場の成長によるものである。新興市場は製薬企業に新たな機会をもたらす。 スコープ - 世界の医薬品市場の規模、成長、主要プレイヤーを特定することで、エントリーレベルの調査にかかる時間を短縮 - ファイブフォース分析により、世界の医薬品市場の競争力および魅力を把握 - 主要企業のプロフィールから、医薬品市場の主要プレイヤーの世界的な事業展開と財務実績の詳細を明らかにします。 - 世界の医薬品市場の将来成長見通しを5年予測で把握することで、プレゼンテーションやピッチに重みを加える 購入の理由 - 2022年の世界の医薬品市場規模は? - 2027年の医薬品世界市場規模は? - 世界の医薬品市場の競争力に影響を与える要因は何か? - 過去5年間の市場の推移は? - 世界の医薬品市場における上位競合企業は? 目次Table of Contents1 EXECUTIVE SUMMARY 1.1. Market value 1.2. Market value forecast 1.3. Geography segmentation 1.4. Market share 1.5. Competitive landscape 2 Introduction 2.1. What is this report about? 2.2. Who is the target reader? 2.3. How to use this report 2.4. Definitions 3 Global Pharmaceuticals 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in Asia-Pacific 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Pharmaceuticals in Europe 6.1. Market Overview 6.2. Market Data 6.3. Market Segmentation 6.4. Market outlook 6.5. Five forces analysis 7 Macroeconomic Indicators 7.1. Country data 8 Pharmaceuticals in France 8.1. Market Overview 8.2. Market Data 8.3. Market Segmentation 8.4. Market outlook 8.5. Five forces analysis 9 Macroeconomic Indicators 9.1. Country data 10 Pharmaceuticals in Germany 10.1. Market Overview 10.2. Market Data 10.3. Market Segmentation 10.4. Market outlook 10.5. Five forces analysis 11 Macroeconomic Indicators 11.1. Country data 12 Pharmaceuticals in Italy 12.1. Market Overview 12.2. Market Data 12.3. Market Segmentation 12.4. Market outlook 12.5. Five forces analysis 13 Macroeconomic Indicators 13.1. Country data 14 Pharmaceuticals in Japan 14.1. Market Overview 14.2. Market Data 14.3. Market Segmentation 14.4. Market outlook 14.5. Five forces analysis 15 Macroeconomic Indicators 15.1. Country data 16 Pharmaceuticals in Australia 16.1. Market Overview 16.2. Market Data 16.3. Market Segmentation 16.4. Market outlook 16.5. Five forces analysis 17 Macroeconomic Indicators 17.1. Country data 18 Pharmaceuticals in Canada 18.1. Market Overview 18.2. Market Data 18.3. Market Segmentation 18.4. Market outlook 18.5. Five forces analysis 19 Macroeconomic Indicators 19.1. Country data 20 Pharmaceuticals in China 20.1. Market Overview 20.2. Market Data 20.3. Market Segmentation 20.4. Market outlook 20.5. Five forces analysis 21 Macroeconomic Indicators 21.1. Country data 22 Pharmaceuticals in The Netherlands 22.1. Market Overview 22.2. Market Data 22.3. Market Segmentation 22.4. Market outlook 22.5. Five forces analysis 23 Macroeconomic Indicators 23.1. Country data 24 Pharmaceuticals in Spain 24.1. Market Overview 24.2. Market Data 24.3. Market Segmentation 24.4. Market outlook 24.5. Five forces analysis 25 Macroeconomic Indicators 25.1. Country data 26 Pharmaceuticals in The United Kingdom 26.1. Market Overview 26.2. Market Data 26.3. Market Segmentation 26.4. Market outlook 26.5. Five forces analysis 27 Macroeconomic Indicators 27.1. Country data 28 Pharmaceuticals in The United States 28.1. Market Overview 28.2. Market Data 28.3. Market Segmentation 28.4. Market outlook 28.5. Five forces analysis 29 Macroeconomic Indicators 29.1. Country data 30 Company Profiles 30.1. Bayer AG 30.2. Novartis AG 30.3. Takeda Pharmaceutical Company Limited 30.4. Sanofi SA 30.5. Laboratoires Pierre Fabre SA 30.6. Les Laboratoires Servier 30.7. F. Hoffmann-La Roche Ltd 30.8. Boehringer Ingelheim GmbH 30.9. A Menarini Industrie Farmaceutiche Riunite Srl 30.10. Recordati S.p.A. 30.11. Chiesi Farmaceutici SpA 30.12. Daiichi Sankyo Co Ltd 30.13. Astellas Pharma Inc. 30.14. Mitsubishi Tanabe Pharma Corporation 30.15. Aspen Pharmacare Holdings Ltd 30.16. Apotex, Inc. 30.17. Yangtze River Pharmaceutical Group 30.18. Shanghai Pharmaceuticals Holding Co Ltd 30.19. Yunnan Baiyao Group Co Ltd 30.20. Guangzhou Pharmaceutical Holdings Ltd 30.21. Almirall S.A. 30.22. GSK plc. 30.23. Johnson & Johnson 30.24. Merck & Co., Inc. 30.25. Pfizer Inc. 30.26. AstraZeneca PLC 31 Appendix 31.1. Methodology 31.2. About MarketLine 図表リストList of TablesTable 1: Global pharmaceuticals market value: $ billion, 2017-22 Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2022 Table 3: Global pharmaceuticals market share: % share, by value, 2022 Table 4: Global pharmaceuticals market value forecast: $ billion, 2022–27 Table 5: Global size of population (million), 2018–22 Table 6: Global gdp (constant 2005 prices, $ billion), 2018–22 Table 7: Global gdp (current prices, $ billion), 2018–22 Table 8: Global inflation, 2018–22 Table 9: Global consumer price index (absolute), 2018–22 Table 10: Global exchange rate, 2018–22 Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22 Table 12: Asia–Pacific pharmaceuticals market geography segmentation: $ billion, 2022 Table 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022–27 Table 14: Europe pharmaceuticals market value: $ billion, 2017-22 Table 15: Europe pharmaceuticals market geography segmentation: $ billion, 2022 Table 16: Europe pharmaceuticals market value forecast: $ billion, 2022–27 Table 17: Europe size of population (million), 2018–22 Table 18: Europe gdp (constant 2005 prices, $ billion), 2018–22 Table 19: Europe gdp (current prices, $ billion), 2018–22 Table 20: Europe inflation, 2018–22 Table 21: Europe consumer price index (absolute), 2018–22 Table 22: Europe exchange rate, 2018–22 Table 23: France pharmaceuticals market value: $ billion, 2017-22 Table 24: France pharmaceuticals market geography segmentation: $ billion, 2022 Table 25: France pharmaceuticals market value forecast: $ billion, 2022–27 Table 26: France size of population (million), 2018–22 Table 27: France gdp (constant 2005 prices, $ billion), 2018–22 Table 28: France gdp (current prices, $ billion), 2018–22 Table 29: France inflation, 2018–22 Table 30: France consumer price index (absolute), 2018–22 Table 31: France exchange rate, 2018–22 Table 32: Germany pharmaceuticals market value: $ billion, 2017-22 Table 33: Germany pharmaceuticals market geography segmentation: $ billion, 2022 Table 34: Germany pharmaceuticals market value forecast: $ billion, 2022–27 Table 35: Germany size of population (million), 2018–22 Table 36: Germany gdp (constant 2005 prices, $ billion), 2018–22 Table 37: Germany gdp (current prices, $ billion), 2018–22 Table 38: Germany inflation, 2018–22 Table 39: Germany consumer price index (absolute), 2018–22 Table 40: Germany exchange rate, 2018–22 Table 41: Italy pharmaceuticals market value: $ billion, 2017-22 Table 42: Italy pharmaceuticals market geography segmentation: $ billion, 2022 Table 43: Italy pharmaceuticals market value forecast: $ billion, 2022–27 Table 44: Italy size of population (million), 2018–22 Table 45: Italy gdp (constant 2005 prices, $ billion), 2018–22 Table 46: Italy gdp (current prices, $ billion), 2018–22 Table 47: Italy inflation, 2018–22 Table 48: Italy consumer price index (absolute), 2018–22 Table 49: Italy exchange rate, 2018–22 Table 50: Japan pharmaceuticals market value: $ billion, 2017-22 Table 51: Japan pharmaceuticals market geography segmentation: $ billion, 2022 Table 52: Japan pharmaceuticals market value forecast: $ billion, 2022–27 Table 53: Japan size of population (million), 2018–22 Table 54: Japan gdp (constant 2005 prices, $ billion), 2018–22 Table 55: Japan gdp (current prices, $ billion), 2018–22 Table 56: Japan inflation, 2018–22 Table 57: Japan consumer price index (absolute), 2018–22 Table 58: Japan exchange rate, 2018–22 Table 59: Australia pharmaceuticals market value: $ billion, 2017-22 Table 60: Australia pharmaceuticals market geography segmentation: $ billion, 2022 Table 61: Australia pharmaceuticals market value forecast: $ billion, 2022–27 Table 62: Australia size of population (million), 2018–22 Table 63: Australia gdp (constant 2005 prices, $ billion), 2018–22 Table 64: Australia gdp (current prices, $ billion), 2018–22 Table 65: Australia inflation, 2018–22 Table 66: Australia consumer price index (absolute), 2018–22 Table 67: Australia exchange rate, 2018–22 Table 68: Canada pharmaceuticals market value: $ billion, 2017-22 Table 69: Canada pharmaceuticals market geography segmentation: $ billion, 2022 Table 70: Canada pharmaceuticals market value forecast: $ billion, 2022–27 Table 71: Canada size of population (million), 2018–22 Table 72: Canada gdp (constant 2005 prices, $ billion), 2018–22 Table 73: Canada gdp (current prices, $ billion), 2018–22 Table 74: Canada inflation, 2018–22 Table 75: Canada consumer price index (absolute), 2018–22 Table 76: Canada exchange rate, 2018–22 Table 77: China pharmaceuticals market value: $ billion, 2017-22 Table 78: China pharmaceuticals market geography segmentation: $ billion, 2022 Table 79: China pharmaceuticals market value forecast: $ billion, 2022–27 Table 80: China size of population (million), 2018–22 Table 81: China gdp (constant 2005 prices, $ billion), 2018–22 Table 82: China gdp (current prices, $ billion), 2018–22 Table 83: China inflation, 2018–22 Table 84: China consumer price index (absolute), 2018–22 Table 85: China exchange rate, 2018–22 Table 86: Netherlands pharmaceuticals market value: $ billion, 2017-22 Table 87: Netherlands pharmaceuticals market geography segmentation: $ billion, 2022 Table 88: Netherlands pharmaceuticals market value forecast: $ billion, 2022–27 Table 89: Netherlands size of population (million), 2018–22 Table 90: Netherlands gdp (constant 2005 prices, $ billion), 2018–22 Table 91: Netherlands gdp (current prices, $ billion), 2018–22 Table 92: Netherlands inflation, 2018–22 Table 93: Netherlands consumer price index (absolute), 2018–22 Table 94: Netherlands exchange rate, 2018–22 Table 95: Spain pharmaceuticals market value: $ billion, 2017-22 Table 96: Spain pharmaceuticals market geography segmentation: $ billion, 2022 Table 97: Spain pharmaceuticals market value forecast: $ billion, 2022–27 Table 98: Spain size of population (million), 2018–22 Table 99: Spain gdp (constant 2005 prices, $ billion), 2018–22 Table 100: Spain gdp (current prices, $ billion), 2018–22 Table 101: Spain inflation, 2018–22 Table 102: Spain consumer price index (absolute), 2018–22 Table 103: Spain exchange rate, 2018–22 Table 104: United Kingdom pharmaceuticals market value: $ billion, 2017-22 Table 105: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2022
SummaryPharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 Table of ContentsTable of Contents1 EXECUTIVE SUMMARY 1.1. Market value 1.2. Market value forecast 1.3. Geography segmentation 1.4. Market share 1.5. Competitive landscape 2 Introduction 2.1. What is this report about? 2.2. Who is the target reader? 2.3. How to use this report 2.4. Definitions 3 Global Pharmaceuticals 3.1. Market Overview 3.2. Market Data 3.3. Market Segmentation 3.4. Market outlook 3.5. Five forces analysis 4 Macroeconomic Indicators 4.1. Country data 5 Pharmaceuticals in Asia-Pacific 5.1. Market Overview 5.2. Market Data 5.3. Market Segmentation 5.4. Market outlook 5.5. Five forces analysis 6 Pharmaceuticals in Europe 6.1. Market Overview 6.2. Market Data 6.3. Market Segmentation 6.4. Market outlook 6.5. Five forces analysis 7 Macroeconomic Indicators 7.1. Country data 8 Pharmaceuticals in France 8.1. Market Overview 8.2. Market Data 8.3. Market Segmentation 8.4. Market outlook 8.5. Five forces analysis 9 Macroeconomic Indicators 9.1. Country data 10 Pharmaceuticals in Germany 10.1. Market Overview 10.2. Market Data 10.3. Market Segmentation 10.4. Market outlook 10.5. Five forces analysis 11 Macroeconomic Indicators 11.1. Country data 12 Pharmaceuticals in Italy 12.1. Market Overview 12.2. Market Data 12.3. Market Segmentation 12.4. Market outlook 12.5. Five forces analysis 13 Macroeconomic Indicators 13.1. Country data 14 Pharmaceuticals in Japan 14.1. Market Overview 14.2. Market Data 14.3. Market Segmentation 14.4. Market outlook 14.5. Five forces analysis 15 Macroeconomic Indicators 15.1. Country data 16 Pharmaceuticals in Australia 16.1. Market Overview 16.2. Market Data 16.3. Market Segmentation 16.4. Market outlook 16.5. Five forces analysis 17 Macroeconomic Indicators 17.1. Country data 18 Pharmaceuticals in Canada 18.1. Market Overview 18.2. Market Data 18.3. Market Segmentation 18.4. Market outlook 18.5. Five forces analysis 19 Macroeconomic Indicators 19.1. Country data 20 Pharmaceuticals in China 20.1. Market Overview 20.2. Market Data 20.3. Market Segmentation 20.4. Market outlook 20.5. Five forces analysis 21 Macroeconomic Indicators 21.1. Country data 22 Pharmaceuticals in The Netherlands 22.1. Market Overview 22.2. Market Data 22.3. Market Segmentation 22.4. Market outlook 22.5. Five forces analysis 23 Macroeconomic Indicators 23.1. Country data 24 Pharmaceuticals in Spain 24.1. Market Overview 24.2. Market Data 24.3. Market Segmentation 24.4. Market outlook 24.5. Five forces analysis 25 Macroeconomic Indicators 25.1. Country data 26 Pharmaceuticals in The United Kingdom 26.1. Market Overview 26.2. Market Data 26.3. Market Segmentation 26.4. Market outlook 26.5. Five forces analysis 27 Macroeconomic Indicators 27.1. Country data 28 Pharmaceuticals in The United States 28.1. Market Overview 28.2. Market Data 28.3. Market Segmentation 28.4. Market outlook 28.5. Five forces analysis 29 Macroeconomic Indicators 29.1. Country data 30 Company Profiles 30.1. Bayer AG 30.2. Novartis AG 30.3. Takeda Pharmaceutical Company Limited 30.4. Sanofi SA 30.5. Laboratoires Pierre Fabre SA 30.6. Les Laboratoires Servier 30.7. F. Hoffmann-La Roche Ltd 30.8. Boehringer Ingelheim GmbH 30.9. A Menarini Industrie Farmaceutiche Riunite Srl 30.10. Recordati S.p.A. 30.11. Chiesi Farmaceutici SpA 30.12. Daiichi Sankyo Co Ltd 30.13. Astellas Pharma Inc. 30.14. Mitsubishi Tanabe Pharma Corporation 30.15. Aspen Pharmacare Holdings Ltd 30.16. Apotex, Inc. 30.17. Yangtze River Pharmaceutical Group 30.18. Shanghai Pharmaceuticals Holding Co Ltd 30.19. Yunnan Baiyao Group Co Ltd 30.20. Guangzhou Pharmaceutical Holdings Ltd 30.21. Almirall S.A. 30.22. GSK plc. 30.23. Johnson & Johnson 30.24. Merck & Co., Inc. 30.25. Pfizer Inc. 30.26. AstraZeneca PLC 31 Appendix 31.1. Methodology 31.2. About MarketLine List of Tables/GraphsList of TablesTable 1: Global pharmaceuticals market value: $ billion, 2017-22 Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2022 Table 3: Global pharmaceuticals market share: % share, by value, 2022 Table 4: Global pharmaceuticals market value forecast: $ billion, 2022–27 Table 5: Global size of population (million), 2018–22 Table 6: Global gdp (constant 2005 prices, $ billion), 2018–22 Table 7: Global gdp (current prices, $ billion), 2018–22 Table 8: Global inflation, 2018–22 Table 9: Global consumer price index (absolute), 2018–22 Table 10: Global exchange rate, 2018–22 Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22 Table 12: Asia–Pacific pharmaceuticals market geography segmentation: $ billion, 2022 Table 13: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022–27 Table 14: Europe pharmaceuticals market value: $ billion, 2017-22 Table 15: Europe pharmaceuticals market geography segmentation: $ billion, 2022 Table 16: Europe pharmaceuticals market value forecast: $ billion, 2022–27 Table 17: Europe size of population (million), 2018–22 Table 18: Europe gdp (constant 2005 prices, $ billion), 2018–22 Table 19: Europe gdp (current prices, $ billion), 2018–22 Table 20: Europe inflation, 2018–22 Table 21: Europe consumer price index (absolute), 2018–22 Table 22: Europe exchange rate, 2018–22 Table 23: France pharmaceuticals market value: $ billion, 2017-22 Table 24: France pharmaceuticals market geography segmentation: $ billion, 2022 Table 25: France pharmaceuticals market value forecast: $ billion, 2022–27 Table 26: France size of population (million), 2018–22 Table 27: France gdp (constant 2005 prices, $ billion), 2018–22 Table 28: France gdp (current prices, $ billion), 2018–22 Table 29: France inflation, 2018–22 Table 30: France consumer price index (absolute), 2018–22 Table 31: France exchange rate, 2018–22 Table 32: Germany pharmaceuticals market value: $ billion, 2017-22 Table 33: Germany pharmaceuticals market geography segmentation: $ billion, 2022 Table 34: Germany pharmaceuticals market value forecast: $ billion, 2022–27 Table 35: Germany size of population (million), 2018–22 Table 36: Germany gdp (constant 2005 prices, $ billion), 2018–22 Table 37: Germany gdp (current prices, $ billion), 2018–22 Table 38: Germany inflation, 2018–22 Table 39: Germany consumer price index (absolute), 2018–22 Table 40: Germany exchange rate, 2018–22 Table 41: Italy pharmaceuticals market value: $ billion, 2017-22 Table 42: Italy pharmaceuticals market geography segmentation: $ billion, 2022 Table 43: Italy pharmaceuticals market value forecast: $ billion, 2022–27 Table 44: Italy size of population (million), 2018–22 Table 45: Italy gdp (constant 2005 prices, $ billion), 2018–22 Table 46: Italy gdp (current prices, $ billion), 2018–22 Table 47: Italy inflation, 2018–22 Table 48: Italy consumer price index (absolute), 2018–22 Table 49: Italy exchange rate, 2018–22 Table 50: Japan pharmaceuticals market value: $ billion, 2017-22 Table 51: Japan pharmaceuticals market geography segmentation: $ billion, 2022 Table 52: Japan pharmaceuticals market value forecast: $ billion, 2022–27 Table 53: Japan size of population (million), 2018–22 Table 54: Japan gdp (constant 2005 prices, $ billion), 2018–22 Table 55: Japan gdp (current prices, $ billion), 2018–22 Table 56: Japan inflation, 2018–22 Table 57: Japan consumer price index (absolute), 2018–22 Table 58: Japan exchange rate, 2018–22 Table 59: Australia pharmaceuticals market value: $ billion, 2017-22 Table 60: Australia pharmaceuticals market geography segmentation: $ billion, 2022 Table 61: Australia pharmaceuticals market value forecast: $ billion, 2022–27 Table 62: Australia size of population (million), 2018–22 Table 63: Australia gdp (constant 2005 prices, $ billion), 2018–22 Table 64: Australia gdp (current prices, $ billion), 2018–22 Table 65: Australia inflation, 2018–22 Table 66: Australia consumer price index (absolute), 2018–22 Table 67: Australia exchange rate, 2018–22 Table 68: Canada pharmaceuticals market value: $ billion, 2017-22 Table 69: Canada pharmaceuticals market geography segmentation: $ billion, 2022 Table 70: Canada pharmaceuticals market value forecast: $ billion, 2022–27 Table 71: Canada size of population (million), 2018–22 Table 72: Canada gdp (constant 2005 prices, $ billion), 2018–22 Table 73: Canada gdp (current prices, $ billion), 2018–22 Table 74: Canada inflation, 2018–22 Table 75: Canada consumer price index (absolute), 2018–22 Table 76: Canada exchange rate, 2018–22 Table 77: China pharmaceuticals market value: $ billion, 2017-22 Table 78: China pharmaceuticals market geography segmentation: $ billion, 2022 Table 79: China pharmaceuticals market value forecast: $ billion, 2022–27 Table 80: China size of population (million), 2018–22 Table 81: China gdp (constant 2005 prices, $ billion), 2018–22 Table 82: China gdp (current prices, $ billion), 2018–22 Table 83: China inflation, 2018–22 Table 84: China consumer price index (absolute), 2018–22 Table 85: China exchange rate, 2018–22 Table 86: Netherlands pharmaceuticals market value: $ billion, 2017-22 Table 87: Netherlands pharmaceuticals market geography segmentation: $ billion, 2022 Table 88: Netherlands pharmaceuticals market value forecast: $ billion, 2022–27 Table 89: Netherlands size of population (million), 2018–22 Table 90: Netherlands gdp (constant 2005 prices, $ billion), 2018–22 Table 91: Netherlands gdp (current prices, $ billion), 2018–22 Table 92: Netherlands inflation, 2018–22 Table 93: Netherlands consumer price index (absolute), 2018–22 Table 94: Netherlands exchange rate, 2018–22 Table 95: Spain pharmaceuticals market value: $ billion, 2017-22 Table 96: Spain pharmaceuticals market geography segmentation: $ billion, 2022 Table 97: Spain pharmaceuticals market value forecast: $ billion, 2022–27 Table 98: Spain size of population (million), 2018–22 Table 99: Spain gdp (constant 2005 prices, $ billion), 2018–22 Table 100: Spain gdp (current prices, $ billion), 2018–22 Table 101: Spain inflation, 2018–22 Table 102: Spain consumer price index (absolute), 2018–22 Table 103: Spain exchange rate, 2018–22 Table 104: United Kingdom pharmaceuticals market value: $ billion, 2017-22 Table 105: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2022
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
MarketLine 社の最新刊レポート本レポートと同じKEY WORD(competitive analysis)の最新刊レポートよくあるご質問MarketLine社はどのような調査会社ですか?マーケットライン(MarketLine)は、世界の産業および企業を国別や業種別に詳細に調査し、調査レポートを積極的に出版しています。また世界の企業を幅広く対象に様々な角度から調査した企業レポートも出版... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/09 10:27 143.78 円 159.73 円 191.51 円 |